- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-06-0002250

About Surya Life Sciences Limited
Data last updated:
Surya Life Sciences Limited is a public limited company based in Navi Mumbai, Maharashtra, India. It operates in the aromatics and benzene derivatives segment of the chemicals and materials sector. It was incorporated on 04 July 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PLC154467. Its GSTIN is 24AAJCS3126R1ZX (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6.1 Cr and a paid-up capital of ₹5.99 Cr. It is led by directors including Neha Yash Joshi and Arun Durgaprasad Joshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 206 Radhamit Society Plot No 33 Sector 18 Nerul West, Navi Mumbai, Maharashtra, India – 400706.
As per the financials filed for FY 2025, the company reported a revenue of ₹118.61 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹5.17 Cr (net margin 4.4%) and EBITDA of ₹11.34 Cr (EBITDA margin 9.6%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 14% over five years.
The company has about 40 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹39.5 Cr and satisfied charges of ₹52.61 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending. The company has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹5.76 Cr; the latest was in December 2022. Its 8 peer companies in the Chemicals industry (API Manufacturers, Aromatics), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Kimia Biosciences Limited with revenue of ₹120.24 Cr.
Surya Life Sciences Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0002250). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website suryalifesciences.com.
Company details
CIN history
Surya Life Sciences has one previous CIN (Corporate Identification Number): U24230MH2005PTC154467. The current CIN is U24230MH2005PLC154467, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2005PLC154467 | Current |
| U24230MH2005PTC154467 | Previous |
Recognitions & Rankings of Surya Life Sciences
Contact details
Surya Life Sciences Limited's registered office is in Navi Mumbai, Maharashtra. Its website is suryalifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB – 206 Radhamit Society Plot No 33 Sector 18 Nerul West, Navi Mumbai, Maharashtra, India – 400706
- IndustryChemicals and Materials, Aromatics & Benzene Derivatives
To see the full contact details of Surya Life Sciences Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Surya Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Surya Life Sciences Limited, buy the company report.
Financials of Surya Life Sciences Limited
FY 2025 filings availableSurya Life Sciences Limited reported revenue of ₹118.61 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 12% growth in the latest year. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.34 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.17 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.6% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Surya Life Sciences Limited, buy the company report.
Board of directors of Surya Life Sciences Limited
Surya Life Sciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neha Yash Joshi Also directs: Griffith Overseas Private Limited | Director | 16 Feb 2022 | 4 Years 9 Months | Current |
| Arun Durgaprasad Joshi Also directs: Surya Remedies Private Limited, Solana Life Sciences Private Limited, Witting Biotech Private Limited and 3 more | Director | 04 Jul 2005 | 21 Years 4 Months | Current |
| Sandhya Arunbhai Joshi | Director | 04 Jul 2005 | 21 Years 4 Months | Current |
| Yash Arun Joshi Also directs: Surya Remedies Private Limited, Solana Life Sciences Private Limited, Witting Biotech Private Limited and 1 more | Director | 04 Jul 2005 | 21 Years 4 Months | Current |
Peer comparison
Surya Life Sciences Limited is compared with the 8 companies closest to it by revenue in the Chemicals industry (API Manufacturers, Aromatics), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kimia Biosciences Limited | ₹120.24 Cr (FY 2025) | 13.0% | Gurgaon, Haryana, India | |||
| Galaxy Laboratories Private Limited | ₹120.18 Cr (FY 2025) | 17.0% | Aurangabad, Maharashtra, India | |||
| Vartika Chemicals & Pharmaceuticals Private Limited | ₹120.07 Cr (FY 2025) | -17.0% | New Delhi, Delhi, India | |||
| Virchow Chemicals Pvt. Ltd. | ₹120.01 Cr (FY 2020) | -26.0% | Hyderabad, Telangana, India | |||
| Surya Life Sciences Limitedthis company | ₹118.61 Cr (FY 2025) | ₹5.17 Cr | 4.4% | 12.0% | 40 | Navi Mumbai, Maharashtra, India |
| Lactose (India) Limited | ₹117.85 Cr (FY 2025) | 2.0% | Poicha, Gujarat, India | |||
| Prachem Laboratories Private Limited | ₹117.4 Cr (FY 2025) | -6.0% | Gandhinagar, Gujarat, India | |||
| Shree Balaji Aromatics Private Limited | ₹115.95 Cr (FY 2025) | -1.0% | Uttar Pradesh, India | |||
| Aastrid Life Sciences Private Limited | ₹115.25 Cr (FY 2025) | 6.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Surya Life Sciences Limited, buy the company report.
Auditor
Surya Life Sciences Limited is audited by SHAH AKSHAY & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHAH AKSHAY & ASSOCIATES | FY 2023 | 143258W |
Shareholding
The shareholding of Surya Life Sciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Surya Life Sciences Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Nov 2023 | 100810655 | Others | ₹29.5 Cr | Open | |
| 03 Nov 2023 | 100810685 | Others | ₹10 Cr | Open | |
| 24 Mar 2023 | 100698238 | Axis Bank Limited | ₹2 Cr | Satisfied | |
| 22 Oct 2020 | 100387337 | Axis Bank Limited | ₹19.76 Lakh | Satisfied | |
| 11 Jan 2019 | 100235318 | Axis Bank Limited | ₹7.29 Lakh | Satisfied |
To see the full charge records of Surya Life Sciences Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Surya Life Sciences Limited has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹5.76 Cr; the latest was in December 2022.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Mar 2016 | Funding round | ₹2.45 Cr | Investors: 2 individuals |
| Mar 2014 | Funding round | ₹1.13 Cr | Investors: 4 individuals |
| Mar 2012 | Funding round | ₹2.18 Cr | Investors: Surya Remedies Private Limited , 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Surya Life Sciences Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Bharuch, Gujarat | Civil suit | Filed against the company by Organic Industries Private Limited Through It,S A.R., Mr.Ashok Biswal | Disposed |
| District court, Bharuch, Gujarat | Court case (WC-NFATAL-L) | Filed against the company by an individual | Pending |
To see the full case history of Surya Life Sciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Surya Life Sciences Limited was last rated by Icra on 04 Dec 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 04 Dec 2020 |
To see the full credit ratings and regulatory alerts of Surya Life Sciences Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Surya Life Sciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Surya Life Sciences Limited has a workforce of 40 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 40 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Surya Life Sciences Limited, buy the company report.
GST
Surya Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCS3126R1ZX | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Surya Life Sciences Limited, buy the company report.
Recent activity
Surya Life Sciences Limited has 5 board changes on record since 2005: 4 appointments and 1 cessation. The latest: Neha Yash Joshi was appointed as Director on 16 Feb 2022.
13 earlier events are in the company report.
Frequently asked questions
Surya Life Sciences is an active public limited company based in Navi Mumbai, Maharashtra, India. The company works in aromatics and benzene derivatives, within the chemicals and materials industry. It was incorporated on 04 July 2005 (21+ years old) and is registered under CIN U24230MH2005PLC154467.
Surya Life Sciences has 4 current directors:
- Neha Yash Joshi - Director
- Arun Durgaprasad Joshi - Director
- Sandhya Arunbhai Joshi - Director
- Yash Arun Joshi - Director
The latest financial statements of Surya Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Surya Life Sciences is 24AAJCS3126R1ZX, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Surya Life Sciences is U24230MH2005PLC154467. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Surya Life Sciences has 2 court cases on record: 2 filed against it. 1 is pending.
Surya Life Sciences was incorporated on 04 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Surya Life Sciences has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹5.76 Cr; the latest was in December 2022.
The peers of Surya Life Sciences by revenue are Kimia Biosciences Limited, Galaxy Laboratories Private Limited, Vartika Chemicals & Pharmaceuticals Private Limited, Virchow Chemicals Pvt. Ltd, Lactose (India) Limited and 3 more, all in the Chemicals industry (API Manufacturers, Aromatics), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Neha Yash Joshi was appointed as Director on 16 Feb 2022. Priti Arun Joshi ceased to be Director on 18 Oct 2012. Arun Durgaprasad Joshi was appointed as Director on 04 Jul 2005. Surya Life Sciences has 5 board changes on record in total.
Yes, Surya Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-06-0002250).

